# | Title | Journal | Year | Citations |
---|
1 | The status of the sensitization/kindling hypothesis of bipolar disorder | Current Psychosis & Therapeutics Reports | 2004 | 12 |
2 | Caregiver burden in dementia care: Prevalence and health effects | Current Psychosis & Therapeutics Reports | 2005 | 10 |
3 | Cognitive disturbance in borderline personality disorder: Phenomenologic, social cognitive, and neurocognitive findings | Current Psychosis & Therapeutics Reports | 2006 | 8 |
4 | Dissociative identity disorder | Current Psychosis & Therapeutics Reports | 2006 | 8 |
5 | Optimizing pharmacotherapy of schizophrenia: Tools for the psychiatrist | Current Psychosis & Therapeutics Reports | 2006 | 8 |
6 | Cholinergic mechanisms in schizophrenia: Current concepts | Current Psychosis & Therapeutics Reports | 2006 | 8 |
7 | Evolutionary epidemiology of endophenotypes in the bipolar spectrum: Evolved neuropsychologic mechanisms of social rank | Current Psychosis & Therapeutics Reports | 2006 | 6 |
8 | Bipolar disorder in youth: An update | Current Psychosis & Therapeutics Reports | 2003 | 5 |
9 | Too much or too little pain: The dichotomy of pain sensitivity in psychotic versus other psychiatric disorders | Current Psychosis & Therapeutics Reports | 2006 | 5 |
10 | Attention deficits in the development of schizophrenia: Recent evidence from genetic high-risk and prodromal studies | Current Psychosis & Therapeutics Reports | 2005 | 4 |
11 | Neurocognition in bipolar disorder: A review of the current research | Current Psychosis & Therapeutics Reports | 2004 | 3 |
12 | The neuropsychology of mood disorders | Current Psychosis & Therapeutics Reports | 2005 | 3 |
13 | Psychotic symptoms in the elderly | Current Psychosis & Therapeutics Reports | 2005 | 3 |
14 | Best practice pharmacologic treatment of schizophrenia: Applying principles of evidence-based medicine | Current Psychosis & Therapeutics Reports | 2005 | 3 |
15 | Glutamatergic mechanisms in schizophrenia: Current concepts | Current Psychosis & Therapeutics Reports | 2006 | 3 |
16 | Evidence-based strategies for achieving treatment goals in bipolar disorder: A review and synthesis of contemporary treatment guidelines | Current Psychosis & Therapeutics Reports | 2003 | 2 |
17 | Treating schizophrenia earlier in life and the potential for prevention | Current Psychosis & Therapeutics Reports | 2003 | 2 |
18 | Post-traumatic stress disorder: Differential diagnosis and management | Current Psychosis & Therapeutics Reports | 2004 | 2 |
19 | Precursors of schizophrenia | Current Psychosis & Therapeutics Reports | 2004 | 2 |
20 | Side effects of atypical antipsychotics in the geriatric population | Current Psychosis & Therapeutics Reports | 2005 | 2 |
21 | Emerging novel treatments for severe mood disorders involving cellular plasticity cascades | Current Psychosis & Therapeutics Reports | 2006 | 2 |
22 | Emerging roles of new antipsychotics in bipolar disorders | Current Psychosis & Therapeutics Reports | 2003 | 1 |
23 | Update on the search for genes for bipolar disorder | Current Psychosis & Therapeutics Reports | 2003 | 1 |
24 | Current concepts in rapid cycling bipolar disorder | Current Psychosis & Therapeutics Reports | 2003 | 1 |
25 | Efficacy of second-generation antipsychotics in the treatment of schizophrenia | Current Psychosis & Therapeutics Reports | 2003 | 1 |
26 | Emerging insights on the neuroanatomy of schizophrenia | Current Psychosis & Therapeutics Reports | 2003 | 1 |
27 | Schizophrenia: Causes, course, and neurodevelopment | Current Psychosis & Therapeutics Reports | 2003 | 1 |
28 | Psychosocial therapies in bipolar disorder | Current Psychosis & Therapeutics Reports | 2004 | 1 |
29 | Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: Evidence, limitations, and implications | Current Psychosis & Therapeutics Reports | 2004 | 1 |
30 | Stress, social rhythms, and behavioral activation: Psychosocial factors and the bipolar illness course | Current Psychosis & Therapeutics Reports | 2004 | 1 |
31 | Response to lithium treatment in bipolar disorder as a pharmacogenetic phenotype | Current Psychosis & Therapeutics Reports | 2004 | 1 |
32 | Conduct disorder and other disruptive behaviors: Pediatric psychopharmacology | Current Psychosis & Therapeutics Reports | 2004 | 1 |
33 | Safety profiles of atypical antipsychotics in the elderly | Current Psychosis & Therapeutics Reports | 2004 | 1 |
34 | Vascular depression: Recent advances | Current Psychosis & Therapeutics Reports | 2004 | 1 |
35 | Anticholinergic delirium: Assessing the role of anticholinergic burden in the elderly | Current Psychosis & Therapeutics Reports | 2004 | 1 |
36 | Treating the cognitive deficits of schizophrenia | Current Psychosis & Therapeutics Reports | 2004 | 1 |
37 | Endocrine disorders in schizophrenia: Relationship to antipsychotic therapy | Current Psychosis & Therapeutics Reports | 2004 | 1 |
38 | Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders | Current Psychosis & Therapeutics Reports | 2005 | 1 |
39 | Polypharmacy in schizophrenia: Science, art, and fiction | Current Psychosis & Therapeutics Reports | 2005 | 1 |
40 | Stimulating development of new drugs to improve cognition in schizophrenia | Current Psychosis & Therapeutics Reports | 2005 | 1 |
41 | Cognitive impairment in schizophrenia spectrum personality | Current Psychosis & Therapeutics Reports | 2005 | 1 |
42 | Amphetamine, psychosis, and cognition in the schizophrenia spectrum | Current Psychosis & Therapeutics Reports | 2005 | 1 |
43 | Acute confusional states in the general elderly population: An overview of delirium | Current Psychosis & Therapeutics Reports | 2006 | 1 |
44 | Treatment refractory depression in the elderly: A possible role for repetitive transcranial magnetic stimulation | Current Psychosis & Therapeutics Reports | 2006 | 1 |
45 | Delusional disorders in the elderly | Current Psychosis & Therapeutics Reports | 2006 | 1 |
46 | Serum anticholinergic radioreceptor assay: A selective review of the 25-year history of a simple idea | Current Psychosis & Therapeutics Reports | 2006 | 1 |
47 | Body dysmorphic disorder: Delusions of physical appearance | Current Psychosis & Therapeutics Reports | 2006 | 1 |
48 | Pharmacologic treatment of schizophrenia: Current status and future trends | Current Psychosis & Therapeutics Reports | 2006 | 1 |
49 | New developments in the bipolar spectrum conceptualization | Current Psychosis & Therapeutics Reports | 2003 | 0 |
50 | Safety and tolerability: How do second-generation atypical antipsychotics compare? | Current Psychosis & Therapeutics Reports | 2003 | 0 |